Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Nuvation Bio Inc.NUVB · Entity 4384 | Director | June 09, 2026 | June 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Nuvation Bio Inc.
Report date June 09, 2026 · Filed June 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectBy Trust | 225,000 |
Reported balance
After 2026-06-09 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-06-09 · Purchase · Acquired 25,000 · Balance 225,000 F1: Shares are owned directly by the Robert D. Mashal 2020 Revocable Trust, of which Reporting Person is the sole trustee. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares are owned directly by the Robert D. Mashal 2020 Revocable Trust, of which Reporting Person is the sole trustee.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 09, 2026 Filed Jun 12, 2026 00:02 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | PurchaseClass A Common Stock | 25,000 | $4.73 | $118,250.00 |
DisclosureSEC source: 0002007102-26-000004 · form4-06122026_120648.xml · nonDerivative · entry 1 Mashal Robert · CIK 0002007102 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 225,000 F1 · ownership.nature: Shares are owned directly by the Robert D. Mashal 2020 Revocable Trust, of which Reporting Person is the sole trustee. Read SEC document |
| May 21, 2026 Filed May 27, 2026 00:07 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | GrantStock Option (Right to Buy) · Derivative | 123,397 | $0.00 Strike: $4.79 | $0.00 |
DisclosureSEC source: 0002007102-26-000002 · form4-05272026_120559.xml · derivative · entry 1 Mashal Robert · CIK 0002007102 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,397 Underlying: Class A Common Stock · 123,397 shares Expires 2036-05-20 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2026); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 20:30 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | GiftStock Option (Right to buy) · Derivative | 350,001 | $0.00 Strike: $1.55 | $0.00 |
DisclosureSEC source: 0001415889-25-021652 · form4-08132025_080809.xml · derivative · entry 2 Mashal Robert · CIK 0002007102 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 350,001 Underlying: Class A Common Stock · 350,001 shares Expires 2034-01-07 F1 · derivative.exercise_date: The shares underlying the option are fully vested. F2 · ownership.direct: The reported transaction involves the reporting person's transfer of option to his irrevocable trust. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 20:30 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | GiftStock Option (Right to Buy) · Derivative | 350,001 | $0.00 Strike: $1.55 | $0.00 |
DisclosureSEC source: 0001415889-25-021652 · form4-08132025_080809.xml · derivative · entry 1 Mashal Robert · CIK 0002007102 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 391,178 Underlying: Class A Common Stock · 350,001 shares Expires 2034-01-07 F1 · derivative.exercise_date: The shares underlying the option are fully vested. F2 · ownership.direct: The reported transaction involves the reporting person's transfer of option to his irrevocable trust. Read SEC document |
| May 21, 2025 Filed May 23, 2025 20:05 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | GrantStock Option (Right to Buy) · Derivative | 292,983 | $0.00 Strike: $2.03 | $0.00 |
DisclosureSEC source: 0001415889-25-014420 · form4-05232025_040508.xml · derivative · entry 1 Mashal Robert · CIK 0002007102 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 292,983 Underlying: Class A Common Stock · 292,983 shares Expires 2035-05-20 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2025); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:05 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | PurchaseClass A Common Stock | 98,900 | $1.67 | $165,153.11 |
DisclosureSEC source: 0001415889-25-009908 · form4-04032025_040403.xml · nonDerivative · entry 2 Mashal Robert · CIK 0002007102 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 200,000 F1 · ownership.nature: Shares are owned directly by the Robert D. Mashal 2020 Revocable Trust, of which Reporting Person is the sole trustee. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:05 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | PurchaseClass A Common Stock | 1,100 | $1.67 | $1,832.05 |
DisclosureSEC source: 0001415889-25-009908 · form4-04032025_040403.xml · nonDerivative · entry 1 Mashal Robert · CIK 0002007102 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 101,100 F1 · ownership.nature: Shares are owned directly by the Robert D. Mashal 2020 Revocable Trust, of which Reporting Person is the sole trustee. Read SEC document |
| October 08, 2024 Filed Oct 10, 2024 20:33 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | PurchaseClass A Common Stock | 99,981 | $2.20 | $219,958.20 |
DisclosureSEC source: 0001415889-24-024982 · form4-10102024_081047.xml · nonDerivative · entry 2 Mashal Robert · CIK 0002007102 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 100,000 F1 · ownership.nature: Shares are owned directly by the Robert D. Mashal 2020 Revocable Trust, of which Reporting Person is the sole trustee. Read SEC document |
| October 08, 2024 Filed Oct 10, 2024 20:33 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | PurchaseClass A Common Stock | 19 | $2.20 | $41.71 |
DisclosureSEC source: 0001415889-24-024982 · form4-10102024_081047.xml · nonDerivative · entry 1 Mashal Robert · CIK 0002007102 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 19 F1 · ownership.nature: Shares are owned directly by the Robert D. Mashal 2020 Revocable Trust, of which Reporting Person is the sole trustee. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 21:22 UTC | Nuvation Bio Inc. NUVB · Entity 4384 | GrantStock Option (Right to Buy) · Derivative | 741,179 | $0.00 Strike: $1.55 | $0.00 |
DisclosureSEC source: 0001415889-24-000935 · form4-01102024_090139.xml · derivative · entry 1 Mashal Robert · CIK 0002007102 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 741,179 Underlying: Class A Common Stock · 741,179 shares Expires 2034-01-07 F1 · derivative.exercise_date: 1/36th of the total number of shares shall vest and become exercisable on each monthly anniversary of January 8, 2024, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.